Skip to main content

Dyne Therapeutics, Inc. insider trading

DYNNASDAQ
$15.20-0.62 (-3.92%)as of Oct 2, 2026

“Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise.” — Peter Lynch

Insider Trading vs Stock Price

Insider Trading vs Stock Price data

Showing the 1Y range: Oct 2, 2025 to Oct 2, 2026. Price (+21.1%). 0 insider transactions plotted in this window as 0 markers; nearby trades of the same kind are grouped.

Transactions plotted on the price chart
DateCategoryPersonRoleActionAmountChange in holding
Open market purchase
Open market sell
Marker size reflects transaction size.

Net dollar flow · Buy / Sell balance

Premium
Q2 '25Q3 '25Q4 '25Q1 '26Q2 '26Q3 '26
Unlock quarterly net flow

Key players

  • DKDirk KerstenDirector1.9207%of company
  • JPJason P. RhodesDirector0.2313%of company
  • JCJohn CoxCEO & President0.23%of company
  • OBOxana BeskrovnayaChief Scientific Officer0.1049%of company
  • DKDouglas KerrChief Medical Officer0.0871%of company
  • JFJohanna Friedl-NadererChief Commercial Officer0.0819%of company
  • RWRichard William ScalzoSVP, Head of Finance & Admin.0.0655%of company
  • ELErick LuceraChief Financial Officer0.0641%of company
  • BSBrian S. PosnerDirector0.0131%of company
  • DCDavid Charles LubnerDirector0.00%of company

AI Activity Analysis

Premium
Coming soonAI reads of insider activity will appear here for Premium accounts.

Insider activity

Fromto
CompanyInsider / roleActionΔOwnAvg priceAmount
DYNJohanna Friedl-NadererChief Commercial OfficerOpen market sell$3.49K-0.1%$18.88$3.49KSep 8, 2026Sep 8, 2026
DYNDouglas KerrChief Medical OfficerOpen market sell$24.4K-0.8%$18.88$24.4KSep 8, 2026Sep 8, 2026
DYNJohn CoxCEO & PresidentOpen market sell$107K-1.3%$18.88$107KSep 8, 2026Sep 8, 2026
DYNJohanna Friedl-NadererChief Commercial OfficerOpen market sell$21.9K-0.6%$24.35$21.9KSep 4, 2026Sep 8, 2026
DYNDouglas KerrChief Medical OfficerOpen market sell$91.2K-2.2%$24.35$91.2KSep 4, 2026Sep 8, 2026
DYNJason P. RhodesDirectorOpen market sell$8.06M-42.9%$25.00$8.06MAug 14, 2026Aug 17, 2026
DYNJason P. RhodesDirectorOpen market sell$12M-45.8%$25.00$12MAug 14, 2026Aug 17, 2026
DYNJason P. RhodesDirectorOpen market sell$34M-35.8%$25.00$34MAug 14, 2026Aug 17, 2026
DYNJohanna Friedl-NadererChief Commercial OfficerOpen market sell$5.94K-0.2%$26.28$5.94KAug 13, 2026Aug 17, 2026
DYNDouglas KerrChief Medical OfficerOpen market sell$40.9K-0.9%$26.28$40.9KAug 13, 2026Aug 17, 2026
DYNErick LuceraChief Financial OfficerOpen market sell$47.2K-1.5%$26.28$47.2KAug 13, 2026Aug 17, 2026
DYNJason P. RhodesDirectorOpen market sell$1.67M-7.8%$26.20$1.67MAug 13, 2026Aug 17, 2026
DYNJason P. RhodesDirectorOpen market sell$2.47M-8.3%$26.20$2.47MAug 13, 2026Aug 17, 2026
DYNJason P. RhodesDirectorOpen market sell$7.03M-6.6%$26.20$7.03MAug 13, 2026Aug 17, 2026
DYNJohn CoxCEO & PresidentOpen market sell$131K-1.1%$26.28$131KAug 13, 2026Aug 17, 2026
DYNDirk KerstenDirectorOpen market sell$140K-0.2%$26.04$140KJul 27, 2026Jul 29, 2026
DYNDirk KerstenDirectorOpen market sell$6.53M-6.7%$25.50$6.53MJul 27, 2026Jul 29, 2026
DYNJason P. RhodesDirectorOpen market sell$118K-62.8%$23.61$118KJul 7, 2026Jul 8, 2026
DYNJason P. RhodesDirectorOpen market sell$276K-1.4%$23.62$276KJul 7, 2026Jul 8, 2026
DYNJason P. RhodesDirectorOpen market sell$1.14M-5.6%$23.17$1.14MJul 7, 2026Jul 8, 2026
DYNJason P. RhodesDirectorOpen market sell$351K-1.3%$23.62$351KJul 7, 2026Jul 8, 2026
DYNJason P. RhodesDirectorOpen market sell$1.45M-5.1%$23.17$1.45MJul 7, 2026Jul 8, 2026
DYNJason P. RhodesDirectorOpen market sell$699K-0.7%$23.62$699KJul 7, 2026Jul 8, 2026
DYNJason P. RhodesDirectorOpen market sell$2.88M-2.9%$23.17$2.88MJul 7, 2026Jul 8, 2026
DYNJason P. RhodesDirectorOpen market sell$2.28M-10.3%$22.79$2.28MJul 6, 2026Jul 8, 2026
DYNJason P. RhodesDirectorOpen market sell$2.9M-9.5%$22.79$2.9MJul 6, 2026Jul 8, 2026
DYNJason P. RhodesDirectorOpen market sell$5.77M-5.7%$22.79$5.77MJul 6, 2026Jul 8, 2026
DYNJason P. RhodesDirectorOpen market sell$860K-4.0%$21.14$860KJun 29, 2026Jun 30, 2026
DYNJason P. RhodesDirectorOpen market sell$1.09M-3.7%$21.14$1.09MJun 29, 2026Jun 30, 2026
DYNJason P. RhodesDirectorOpen market sell$2.18M-2.3%$21.14$2.18MJun 29, 2026Jun 30, 2026
DYNJason P. RhodesDirectorOpen market sell$1.37M-6.0%$21.28$1.37MJun 26, 2026Jun 30, 2026
DYNJason P. RhodesDirectorOpen market sell$1.74M-5.5%$21.28$1.74MJun 26, 2026Jun 30, 2026
DYNJason P. RhodesDirectorOpen market sell$3.47M-3.4%$21.28$3.47MJun 26, 2026Jun 30, 2026
DYNJason P. RhodesDirectorOpen market sell$106K-0.5%$21.10$106KJun 25, 2026Jun 26, 2026
DYNJason P. RhodesDirectorOpen market sell$135K-0.4%$21.10$135KJun 25, 2026Jun 26, 2026
DYNJason P. RhodesDirectorOpen market sell$268K-0.3%$21.10$268KJun 25, 2026Jun 26, 2026
DYNErick LuceraChief Financial OfficerOpen market sell$48.1K-1.9%$20.37$48.1KJun 25, 2026Jun 26, 2026
DYNJason P. RhodesDirectorOpen market sell$420K-1.8%$21.02$420KJun 24, 2026Jun 26, 2026
DYNJason P. RhodesDirectorOpen market sell$534K-1.7%$21.02$534KJun 24, 2026Jun 26, 2026
DYNJason P. RhodesDirectorOpen market sell$1.06M-1.1%$21.02$1.06MJun 24, 2026Jun 26, 2026
DYNJason P. RhodesDirectorOpen market sell$650K-2.7%$21.13$650KJun 23, 2026Jun 26, 2026
DYNJason P. RhodesDirectorOpen market sell$827K-2.5%$21.13$827KJun 23, 2026Jun 26, 2026
DYNJason P. RhodesDirectorOpen market sell$1.65M-1.6%$21.13$1.65MJun 23, 2026Jun 26, 2026
DYNDirk KerstenDirectorOpen market sell$35.6K0.0%$21.47$35.6KJun 23, 2026Jun 24, 2026
DYNDirk KerstenDirectorOpen market sell$1.51M-1.8%$21.04$1.51MJun 23, 2026Jun 24, 2026
DYNDirk KerstenDirectorOpen market sell$3.92M-4.6%$20.57$3.92MJun 22, 2026Jun 24, 2026
DYNDirk KerstenDirectorOpen market sell$941K-1.1%$20.07$941KJun 18, 2026Jun 22, 2026
DYNDirk KerstenDirectorOpen market sell$754K-0.9%$20.14$754KJun 17, 2026Jun 22, 2026
DYNJohanna Friedl-NadererChief Commercial OfficerOpen market sell$2.66K-0.1%$18.33$2.66KJun 16, 2026Jun 17, 2026
DYNDouglas KerrChief Medical OfficerOpen market sell$16.3K-0.5%$18.33$16.3KJun 16, 2026Jun 17, 2026
50 of 129 transactions

Not investment advice. We make every effort to keep the information on SpoorBase accurate, but errors may occur. SpoorBase does not guarantee the accuracy or completeness of any data, and any use of the information is at the user’s sole responsibility. Valuation multiples are calculated by SpoorBase and may contain errors. See Disclosures. © 2026 SpoorBase. All rights reserved.